Form 4: American Oncology Network Director Acquires Shares

Stephen Divers, Chief Medical Officer and Director at American Oncology Network, acquired 59,500 shares of Class A Common Stock on March 19, 2024.

Summary

• On March 19, 2024, Stephen Divers, a Director and the Chief Medical Officer of American Oncology Network, Inc. (AONC), acquired 59,500 shares of Class A Common Stock at a price of $5.69 per share.
• Following the transaction, Mr. Divers directly owns 66,024 shares of Class A Common Stock.
• He also indirectly owns 37,499 shares through Divers Investments, LLC and 63,857 shares of Class B Common Stock through the Stephen G. Divers, M.D., Trustee FBO Fred Divers Family Trust.
• 29,750 of the acquired shares vested immediately, with the remaining 29,750 shares vesting on the one-year anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing reflects insider activity within the American Oncology Network, a company in the healthcare sector. Insider transactions are closely watched by investors for signals about a company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates

Keywords

AONC, American Oncology Network, Stephen Divers, Class A Common Stock, Beneficial Ownership, Form 4, Director, Chief Medical Officer